Study finds it suppresses enzyme vital to tumor growth
Posted March 26, 2009
THURSDAY, March 26 (HealthDay News) -- A drug approved to combat AIDS may also help slow the spread of a deadly type of brain tumor that tends to attack children.
A study published in the current issue of the International Journal of Cancer reports that ABC (Abacavir) suppresses the enzyme telomerase. Telomerase activity appears to be essential for certain tumor survival and growth,...
Last Updated: 2009-03-25 10:10:28 -0400 (Reuters Health)
By Karla Gale
NEW YORK (Reuters Health) - Nitric oxide attached to a vitamin B12 analog is a promising cytotoxic agent that targets tumor cells overexpressing B12 receptors, researchers report.
Long-term treatment with this chemotherapeutic agent -- nitrosylcobalamin (NO-Cbl) -- has so far resulted in up to 77% tumor volume reduction in three dogs that had spontaneous carcinoma, with no signs of toxicity,...
New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer – rather than just surviving for at least five years after diagnosis – is rising steadily.
A special issue of the European Journal of Cancer [1] containing reports from the EUROCARE-4 Working Group, includes, for the first time, an estimate of the proportions of patients who are cured of their cancer in Europe and...
ScienceDaily (Mar. 18, 2009) — Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for a children’s brain tumour that currently kills more than 60 per cent of young sufferers.
Clinician –scientists at the University’s Children’s Brain Tumour Research Centre, working on behalf of the Children’s Cancer and Leukaemia Group (CCLG), have studied the role of the WNT biological pathway in central nervous system...
